Biocon Expands Into Middle East With Tabuk Partnership

Tabuk Will Commercialize Select Biocon Generics In The Region

 
• By Chloe Kent

Biocon is set to bolster its planned expansion into the MENA region through a partnership with Saudi firm Tabuk Pharmaceuticals, which will commercialize select Biocon generics in the Middle East.

Biocon logo under magnifying glass
Biocon is expanding into the Middle East through a partnership with Tabuk Pharmaceuticals • Source: Alamy

More from Deals

More from Business